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Cancer invasion and metastasis remains the root cause of mortality. This process involves alterations of
tumor microenvironment, particularly the remodeling of extracellular matrix, characterized by collagen
IV uncoiling, degradation, fragments deposition and cross-linking. Quantum dots-labeled molecular
probes are promising platforms to simultaneously study several subtle changes of key biomolecules,
because of their unique optical and chemical properties. Here we report on a quantum dots-based im-
aging technology to study key components in tumor microenvironment during cancer progression, so as
to gain new insights into the role of collagen IV plays, to deﬁne the cancer “invasion unit” and to develop
the “pulse-mode” of cancer invasion.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY-NC-SA license. 1. Introduction
Cancer is the leading cause of death worldwide, with 7.6 million
people died from cancer per year according to the latest statistics
[1]. Most cancer death is directly due to invasion andmetastasis [2],
which are 2 fundamental properties of cancer biological behaviors,
but the underlying mechanisms of cancer invasion remain elusive.
Many efforts focusing on cancer cells have been made over the past
century, revealing large amount of genetic and epigenetic infor-
mation [3e6]. In the meantime, the last decade has also witnessed
an ever increasing reappraisal of the fundamental concept that
cancer biological processes should be placed into context if we are
to gain meaningful information more applicable to clinics [7e9], in
terms of microenvironment-oriented cancer progression which
means in addition to cancer cells themselves, tumors exhibit
another dimension of complexity, containing a repertoire of
recruited, ostensibly normal cells contributing to the acquisition of
hallmark traits by creating tumor microenvironment. Thus, rich: þ86 27 67812892.
Ltd. Open access under CC BY-NC-SA liceninformation hidden in tumor stroma should be systematically
investigated if a complete understanding of cancer invasion biology
is to be realized.
Of note is the extracellular matrix (ECM), traditionally regarded
as physical scaffolds binding cells and tissues together. ECM
changes are common features of diverse pathological processes,
including tissue ﬁbrosis and cancer [10,11]. In clinical practice, the
correlation between tissue ﬁbrosis and cancer has attracted
increasing attention [12]. As a specialized form of ECM, the base-
ment membrane (BM), lying beneath epithelial and endothelial
cells, plays an important role in cell adhesion, proliferation, dif-
ferentiation, migration and tumor angiogenesis [13,14]. BM is
breached at the site of the vasculature bymetastasizing cancer cells
[15]. From a structural perspective, migrating cells will be con-
fronted with a semi-permeable barrier, the pore size of which is
dictated by both ECM density and cross-linking [16,17].
During cancer invasion, ECM scaffolds undergo considerable
structural remodeling, characterized by increased deposition of
ﬁbronectin, proteoglycans and collagens, and enhancedmatrix cross-
linking [18,19]. Collagens,major constituentsof ECM, serve as effective
barriers [20], can no longer be traditionally considered as a static and
passive background uponwhich metastasis takes place [18]. The bal-
ance of degrading and re-depositing in tumor stroma is brokenwhich
can actively induce epithelialemesenchymal transition (EMT) of
cancer cells [21,22] and stromal cells and immune response tose. 
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tweenECMandcancercells [24]. Epithelial invasion inbothcancerand
branching morphogenesis during development and angiogenesis,
requires cells interact with these collagens [15]. Among various kinds
of collagens, collagen IV is a major component of BM and it provides
scaffold for ECM constituents [13]. Since BM is a physical barrier to
resist cancer invasion, the destruction of collagen IV must be the
prerequisite for cancer invasion and metastasis, for which matrix
metalloproteinases (MMPs) play themost irreplaceable role [25],with
direct causative effects on tumor growth, invasion and angiogenesis
[23,26e28], by a host of mechanobiological mechanisms such as to
degrade collagens to pave a potential tunnel for escaping cancer cells
[25], to disturb tumor microenvironment producing additional me-
chanical force to induce EMT [24], and to expose active sites on
collagen ﬁbers to recruit monocytes leading to a cascade of innate
immuno-inﬂammatory reactions [29]. Based on the dynamic
changes of collagen IV, both immune cells inﬁltration and tumorFig. 1. Typical collagen IV alterations in different tumor tissues. (A1eA3) show linear typ
surrounding GC nests. (C1eC3) show fragmented type of collagen IV depositing in ECM of
arrow heads indicate the sites with collagen IV changes). Scale bar: 50 mm for A1, A2, C1, Cangiogenesis can be activated, to form “tumor microenvironment of
metastasis” [30].
Quantum dots are engineered nanoparticles with special optical
and electronic properties which have promising applications in
biomedicine [31]. Compared with organic dyes and ﬂuorescent
proteins, QDs have unique features such as size and composition-
tunable light emission, enhanced signal brightness, and resistance
to photobleaching [32,33]. This study was designed to harness the
properties of QDs to investigate the dynamic changes of collagen IV
during cancer invasion, so as to better understand the role of tumor
microenvironment in cancer progression.
2. Materials and methods
2.1. Preparation for human cancer tissues
Formalin-ﬁxed parafﬁn-embedded human cancer tissues were obtained from
Zhongnan Hospital of Wuhan University and Central Hospital of Wuhane of collagen IV aligned with HCC nests. (B1eB3) show irregular type of collagen IV
GC. (D1eD3) show collagen IV disappears both in ECM and around tumor nests. (Red
2 & D1; 20 mm for A3, C3, B1, B2, B3, D2 & D3.
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mittee of hospital. Written informed consent was obtained from the patients before
surgery, with permission to use the specimens for scientiﬁc research purposes as
well as clinical pathological studies. According to our previously established tech-
nical procedure [33], tissue sections (4 mm thickness) were treated by deparafﬁ-
nizing, hydration, antigen retrieval, and washing in deionized water before
proceeding to the following imaging studies.
2.2. Immunohistochemistry
For immunohistochemistry (IHC) staining, endogenous peroxidase activity was
blocked by immersing in 3% H2O2 for 10min to prevent any nonspeciﬁc binding. After
blocked with 2% bovine serum albumin (BSA), the slides were ﬁrst incubated with
primary antibodies for rabbit anti-human polyclonal antibody against collagen IV (ab-
6586, Abcam, England, dilution 1/300), mouse anti-human monoclonal antibody
against macrophages (MA1-38069, ABR, USA, dilution 1/300) and goat anti-human
polyclonal antibody against CD105 (sc-20072, Santa Cruz, USA, dilution 1/500) for
2 h at 37 C, then with corresponding secondary antibody, including peroxidase
labeled anti-goat IgG (H þ L) antibody (14-13-06, KPL, USA, dilution 1/300), peroxi-
dase labeled anti-mouse IgG (H þ L) antibody (074-1806, KPL, USA, dilution 1/300)
and peroxidase labeled anti-rabbit IgG (Hþ L) antibody (074-1506, KPL, USA, dilution
1/300) for 30 min at 37 C, respectively. The reaction products were visualized with
diaminobenzidine (DAKO, Denmark). As a negative control, primary antibody was
replaced with Tris-buffered saline on sections that were proven to be positive for
collagen IV, macrophages and CD105 in preliminary experiments.
2.3. QDs-based molecular imaging
For QDs-based immunoﬂuorescent imaging, after being blocked with 2% BSA for
30min at 37 C, slides were incubatedwith above primary antibodies for collagen IV,
macrophages and CD105 at 37 C for 2 h. Then slides were incubated with corre-
sponding secondary antibodies for 2 h at 37 C after another blockade with 2% BSA
for 30 min. The QDs probes were QDs-585 goat F(ab’)2 anti-rabbit IgG conjugate
(Invitrogen, USA, dilution 1/400, emitting yellow light), QDs-525 goat F(ab’)2 anti-
mouse IgG conjugate (Invitrogen, USA, dilution 1/200, emitting green light) and
QDs-655 rabbit F(ab’)2 anti-goat IgG conjugate (Invitrogen, USA, dilution 1/1000,
emitting red light).
For multiplexed QDs staining, a mixture of 3 primary antibodies from different
species (e.g. mouse, rabbit and goat) was used to simultaneously recognize 3 pri-
mary antigens in tissue sections. A mixture of 3 QDs probes was applied to stain the
corresponding antibodies for 2 h at 37 C.Fig. 2. Morphological changes of collagen IV in tumor tissues based on QDs-585 molecu
compared with outer layer, especially at invasion front. (B) Double-layer collagen IV surrou
loose with multiple-layer. (D) Collagen IV in intrahepatic biliary carcinoma nests presents
changes). Scale bar: 10 mm for A, B, C & D.2.4. Image acquisition and processing
Slides were examined under Olympus BX51 ﬂuorescence microscope equipped
with an Olympus DP72 camera (Olympus Optical Co., Ltd., Tokyo, Japan). QDs-
stained slides were excited by ultraviolet light (UV, 330e385 nm) and the images
were captured by DP72 camera.
As QDs images were obtained by simultaneous labeling collagen IV, macro-
phages and CD105, these major constitutes in tumor microenvironment could be
shown in the same tissue slide, making it possible to study the temporal-spatial
changes of these components relative to tumor growth and invasion.
3. Results and discussion
3.1. Characteristics of collagen IV in tumor tissues
Collagen IV, the most abundant constituent of ECM, presents
mainly in stroma to compartmentalize tumor nests. Based on the
morphological characteristics of collagen IV in different tumor
tissues, 4 types of collagen IV alterations could be observed (Fig. 1).
These are: (1) Linear collagen IV in ECM, which forms a stiff and
rigid layer aligned with tumor nests to augment the tensile force
within hepatocellular carcinoma (HCC) (Fig. 1A1eA3); (2) Irregular
collagen IV surrounding tumor nests of gastric cancer (GC)
(Fig. 1B1eB3); (3) Fragmented collagen IV in ECM, in which tumor
nests are immersed (Fig. 1C1eC3); (4) Disappearance of collagen IV
both among tumor nests and in tumor stroma (Fig. 1D1eD3).
Although conspicuous heterogeneous distribution and
morphology of collagen IV are observed, several common features
are evident. For example, the type of irregular collagen IV sur-
rounding tumor nests can be observed in different tumor tissues
(Fig. 2): (1) Collagen IV in breast cancer (BC) usually shows a double-
layer structure surrounding tumor nests,with a fuzzy inner layer and
a discontinuous outer layer extending local protrusions into tumor
stroma, forming invasion front (Fig. 2A); (2) Collagen IV in GC
commonly shows fragmented and distorted double-layer or multi-
layer structure, with many tiny fragments haphazardly scattered inlar imaging. (A) Double-layer collagen IV surrounds BC nests with fuzzy inner layer
nds GC nests with irregular deposition in ECM. (C) Collagen IV surrounding CC nests is
double-layer at invasion front. (Red arrow heads indicate the sites with collagen IV
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(Fig. 2B); (3) Collagen IV in cervical carcinoma (CC) shows a loose and
stratiﬁed structure constraining tumor nests, with many obscure
collagen fragments distributed discretely at the site of BM (Fig. 2C);
(4) Collagen IV in intrahepatic biliary carcinoma often shows a
double-layer structure at invasion front, with rich expression at the
interfaces between two tumor nests (Fig. 2D).
Such different alterations of collagen IV, from abundant to
absent, may indicate the different modes of cancer cells migra-
tion [34,35] related with different invasion patterns as reported
previously in our group [36]. And the common features of
collagen IV, may suggest the same invasion pathway of different
cancers.
3.2. Dynamic changes of collagen IV during invasion of
adenocarcinoma based on GC and HCC
During progression of different pathologic types of GC, collagen
IV and surrounding tumor microenvironment demonstrate signif-
icant heterogeneity in macrophages and tumor neo-vessels.Fig. 3. Dynamic changes of tumor microenvironment in well-differentiated tubular adenoca
shows GC nests are surrounded by intact and dense collagen IV almost without degradation a
front (Red arrows) with increased irregular collagen IV deposition in ECM. (DeF) show incre
CD105 expression in peri-tumor tissue and GC tissue, respectively. (I) shows double-staining
show multiplexed imaging of collagen IV, macrophages and CD105, in which cancer cells, m
“invasion unit”). Scale bar: 50 mm for A, D, E, G, H & J; 20 mm for B, C, F & K; 10 mm for I &In well-differentiated tubular adenocarcinoma, collagen IV is
observed to have dynamic interplays with tumor nests (Fig. 3).
Fig. 3A shows collagen IV expression and macrophages in peri-
tumor tissue of GC. At initial stage of GC invasion, collagen IV in-
creases and encapsulates whole tumor nests to constrain cancer
cells escaping out, in response to tumor nests expansion (Fig. 3B).
Meanwhile, collagen IV undergoes a series of structural changes
such as cross-linking [37] and triple-helix uncoiling [38], in prep-
aration for cancer invasion andmigration. Then, collagen IV aligned
with GC nests forms a double-layer or evenmultiple-layer complex,
which provides space for collagen IV degradation at invasion front
[19]. When invasive cancer cells form cluster protrusions, disap-
pearance of collagen IV could be observed as a result of degrada-
tion, which indicates collective invasion mode of GC (Fig. 3C) [35].
At the same time, this collagen IV degradation at invasion front is
accompanied with increased irregular collagen IV deposition in
ECM. And collagen IV in tumor stroma keeps remodeling to become
stiff and rigid (Fig. 3DeF). Concomitantly, abundant irregular tumor
neo-vessels and macrophage clusters present in ECM (Fig. 3GeI).
Multiplexed imaging clearly shows collagen IV and tumor neo-rcinoma of GC. (A) shows collagen IV and macrophages in peri-tumor tissue of GC. (B)
nd ECM deposition. (C) shows collagen IV aligned with GC nests is degraded at invasion
ased deposition of collagen IV in tumor stroma, presenting stiff and rigid. (GeH) show
of macrophages and CD105 in GC tissue, in which tumor macrophages aggregate. (JeL)
acrophages and tumor neo-vessels constitute “invasion unit” (Red square indicates an
L.
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vascularization. In this way, collagen remodeling disturbs tensional
homeostasis in ECM [39], increases tumor angiogenesis [40] and
induces immune responses to favor cancer invasion and migration
[41]. As well, tumor neo-vessels provide pathways for immune cells
inﬁltration [19], so as to form the so-called “invasion units”, con-
sisted of cancer cells, macrophages and tumor neo-vessels (Fig. 3Je
L). In multiplexed imaging based on QDs, macrophages are green
and tumor neo-vessels expressing CD105 are red. At lower power,
we can observe macrophages mainly distribute in ECM, by which
we can propose that “invasion unit” may preferentially localize to
peripheral aspects of tumor tissues, rather than central. High power
examination reveal macrophages and tumor neo-vessels are
apposed to cancer cells, thus deﬁning as “invasion unit”, otherwise,
the deﬁnition of “invasion unit” is not met.
During progression of poorly-differentiated adenocarcinoma,
tumor stroma shows different features. Collagen IV in tumor
stroma mainly functions as scaffolds for tumor neo-vessels, and
remaining few collagen in tumor stroma presents stiff and rigid
(Fig. 4AeB). Double-staining of tumor neo-vessels and collagen IV
demonstrates collagen IV and tumor neo-vessels occur hand in
hand, conﬁrming that collagen IV provides scaffolds for tumor neo-
vessels (Fig. 4C). Tumor neo-vessels and macrophages in poorly-
differentiated adenocarcinoma are much more abundant than
those in well-differentiated adenocarcinoma (Fig. 4DeE), and the
morphology of macrophages are much more irregular (Fig. 4F). The
multiplexed imaging of collagen IV, macrophages and tumor neo-
vessels shows the close proximity of these 3 components com-
bined with cancer cells, to form “invasion unit” (Fig. 4GeI), and
tumor associated macrophages could be chemo-attracted byFig. 4. Dynamic changes of tumor microenvironment in poorly-differentiated adenocarcino
collagen IV and tumor neo-vessels co-localize in situ. (D) shows abundant tumor neo-vesse
staining of collagen IV and macrophages. (GeI) show multiplexed imaging of collagen IV, m
which the invasion units are much more than well-differentiated GC (Red square indicates acollagen IV remodeling during cancer invasion [42]. Although tu-
mor stroma is less in poorly-differentiated adenocarcinoma than
well-differentiated adenocarcinoma, the “invasion units” are much
more, and are distributed uniformly across an entire tumor. Typi-
cally, they are regarded as single structures scattered throughout
the carcinoma, so the “invasion ﬁeld” consisted of “invasion units”
is much stronger than in well-differentiated adenocarcinoma.
Moreover, in poorly-differentiated adenocarcinoma, single cell
migration based on invasion units is the major mode of cancer
progression, different from but faster than the collective invasion
mode in well-differentiated adenocarcinoma [35]. These features
may account for the worse prognosis of poorly-differentiated
adenocarcinoma.
Based on collagen IV imaging with QDs-585, ECM changes of
HCC can be revealed. In peri-tumor tissues, collagen IV expression
is low in liver parenchyma and absent in stroma (Fig. 5A1eA2). In
liver cirrhosis tissue, collagen IV is randomly distributed in liver
parenchyma tissue accompanied with rich expression in stroma,
still retaining curling and elastic property (Fig. 5B1eB2). In com-
parison, collagen IV in HCC stroma is more abundant, rigid and
aligned with HCC nests (Fig. 5C1eC3). These morphological
changes in collagen IV could have profound impact on biological
behaviors of HCC, as such ECM remodeling in HCC stroma charac-
terized by prominent reorientation of collagen IV is the result of a
continuous degradation and re-patterning of collagen IV, making
collagens harder, increasing mechanical stress in tumor nests
driving cancer cells escaping [24]. It also conﬁrms that chronic
ﬁbrosis is a driving force behind certain cancers and reactive
ﬁbrosis exists at invasion front of invasive cancers. In this way, the
increased collagen density, together with other molecules, decoratema of GC. (AeB) show collagen IV in both tumor nests and tumor stroma. (C) shows
ls among tumor nests. (E) shows rich macrophages in tumor tissue. (F) shows double-
acrophages and tumor neo-vessels in poorly-differentiated adenocarcinoma of GC, of
n “invasion unit”). Scale bar: 50 mm for A, C, D & G; 20 mm for B, E & H; 10 mm for F & I.
Fig. 5. Collagen IV changes in HCC compared with liver cirrhosis and peri-tumor tissues. (A1-A2) show deﬁcient and absent collagen IV expression in peri-tumor tissues of liver.
(B1eB2) show rich and elastic collagen IV in liver cirrhosis tissue. (C1eC3) show rigid and stiff collagen IV in HCC tissues. Scale bar: 100 mm for C1; 50 mm for A1, B1 & C2; 20 mm for
A2, B2 & C3.
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stroma. Further, cancer cells sense differences in physical collagen
properties and migrate preferentially toward regions of increased
stiffness, termed durotaxis, making it easily invade and migrate by
multi-cellular streaming [35]. Consequently, up-regulation of
collagen production in tumor stroma favors cancer cells invasion
and metastasis [39].
3.3. Dynamic changes of collagen IV during invasion of squamous
cell carcinoma based on CC
Key events of cancer invasion are demonstrated by multiple
molecular markers imaging of tumor and peri-tumor tissues. Spe-
cial attention is paid to 3 major components involved in cancer
invasion: monocytes inﬁltration represented by macrophages, tu-
mor vascularization represented by CD105, and tumor stroma
remodeling represented by collagen IV changes. Collagen IV
changes in CC are imaged by both traditional IHC and QDs-based
imaging technology, which reveal smooth, intact and linear
collagen IV well-aligned with BM in peri-tumor tissue (Fig. 6A1e
A2), but this smooth collagen IV line disappears in CC in situ, fol-
lowed by increased collagen IV deposition forming dense layers
(Fig. 6B1eB2), then the dense collagen IV deposition becomes loose
and fuzzy in micro-invasive CC (Fig. 6C1eC2), together with
increased deposition in ECM, leading to rigid and stiff morphology
of collagen IV (Fig. 6D1eD2), accompanied with cancer cells clus-
ters protrusion into CC stroma and neo-vessels formation in ECM
nearby.
In addition, macrophages and tumor neo-vessels present dy-
namic evolution from peri-tumor to invasive CC: (1) In peri-tumor
tissue, there are almost no macrophages and few regular and intact
vessels (Fig. 7A1eA3); (2) In micro-invasive CC, macrophages pre-
sent mainly in stroma accompanied with irregular and incompletetumor neo-vessels (Fig. 7B1eB3); (3) In invasive CC, macrophages
are extensively distributed in small clusters among cancer cells and
in stroma, with prominent tumor neo-vessels surrounding tumor
nests (Fig. 7C1eC3). Meanwhile, macrophages are larger and more
irregular in tumor nests than in ECM. Double-staining of macro-
phages and tumor neo-vessels reveal typical “invasion unit” in
tumor nests (Fig. 7D1eD3).
This dynamic changes of collagen IV during cancer invasion
imply that collagen is not merely a mechanical barrier as is consid-
ered traditionally [20]. Compared with triple-helical structure of
collagen IV with a diameter of 15 nm, structures of the catalytic
domain of MMPs reveal a small catalytic site of approximately 5 nm
[23]. So, before collagen is facilitated by MMPs in an active process
known as “molecular tectonics” [38], collagen IV must undergo
uncoiling, presenting multi-layer at early stage of CC invasion pro-
cess. Furthermore, loose collagen derived from dense andmultiple-
layer collagen followedby increaseddeposition in ECM indicates the
process of degradation of collagen IV and production of collagen IV
peptides. And the latter is reported to expose active sites to induce
tumor angiogenesis [19] and recruitmonocytes, triggering a cascade
of innate immunoeinﬂammatory reactions [43], which is consistent
with results of increased macrophages and neo-vessels observed in
ECM in CC tissues. And also stiff and rigid collagen IV in CC may
function as highways for cancer cells migration, which is reported
that linearization of collagen is most adjacent to tumor vasculature
and in areaswith cancer cells invasion [18]. Such changes of collagen
IVare another frontier to explore the complexmechanismsof cancer
progression from the perspectives of extracellular milieu.
Once again, this study has demonstrated the technical advan-
tages of QDs in multiplexed imaging of tumor environment.
Although the importance of tumormicroenvironmenthas longbeen
recognized, relevant researches in this ﬁeld have been slow and
inadequate,mainly due to technical inadequacies to simultaneously
Fig. 6. Dynamic changes of collagen IV during progression of CC. (A1-A2) show regular and linear collagen IV in peri-tumor tissue. (B1eB2) show multi-layer collagen IV of in situ
CC. (C1eC2) show fuzzy and disappeared collagen IV in micro-invasive CC. (D1-D2) show stiff and rigid collagen IV in stroma of invasive CC. Scale bar: 50 mm for A1, A2, D1 & D2;
20 mm for B1, B2, C1 & C2.
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microenvironment. Currently, IHC is the most widely used method,
but with disadvantages such as prone to interfering factors and
subjective interpretation [33]. And traditional organic ﬂuorescent
dyes are notproper for clinicallyapplicablemolecular pathologydue
to inadequate ﬂuorescent efﬁciency and intensity, poor photo-
stability, and autoﬂuorescence interferences. In contrast, QDs are
not restricted by these disadvantages, with unique properties such
as size- and composition-tunable light emission, enhanced signalbrightness, and resistance to photobleaching. In addition, different
QDscanbe simultaneouslyexcited toemitdifferent colorsbya single
light source,withminimal spectral overlapping [36]. This property is
quite suitable for investigating the mechanisms of cancer progres-
sion by analyzing the co-evolution of cancer cells and their sur-
rounding tumor microenvironment at the architectural level. Thus
the QDs-based multiplexing molecular imaging technology could
help establish a holistic approach to studying the complex biologyof
cancer invasion.
Fig. 7. Comparison between CC tissue and peri-tumor tissue based on multiple molecular biomarkers. (A1), (B1) & (C1) show macrophages in peri-tumor tissue, CC in situ and
invasive CC tissue, respectively. (A2), (B2) & (C2) show tumor neo-vessels in peri-tumor tissue, CC in situ and invasive CC tissue, respectively. (A3), (B3) & (C3) show QDs-based
double-staining of macrophages and tumor neo-vessels in peri-tumor tissue, CC in situ and invasive CC tissue, respectively. (D1eD3) show macrophages and tumor neo-vessels
co-localize in tumor, and macrophages among tumor nests are much larger and more irregular than those in ECM of invasive CC (Red square indicates an “invasion unit”).
Scale bar: 50 mm for A1, A2, A3, B1, B2, B3, C1, C2, C3 & D1; 20 mm for D2; 10 mm for D3.
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during cancer invasion
It has been generally recognized that cancer invasion is a multi-
factor and multi-step continuum, with a variety of molecular dys-
functions and cell signaling deregulations, which ultimately result
in altered tumor microenvironment favoring cancer progression
[44]. The temporal-spatial evolutions of microenvironment and the
interplays between cancer cells and their microenvironment are
critical in every aspect of tumor development, including cancer
cells dormancy, proliferation, invasion and migration [9]. Currently,
the importance of tumor microenvironment has been increasingly
appreciated, from the role of ECM and matrix rigidity in deter-
mining polarity and growth potential of tissues, to the extracellular
metabolism of growth factors and matrix molecules during cancer
progression and metastasis, especially the signiﬁcant role of
collagen [18,24,34].
Collagen IV, one of the most abundant constituent of ECM, is
expressed mainly at BM to constrain cancer cells. As tumor mass
expands, central hypoxia becomes evident, which stimulatescancer cells to secrete LOX (lysyl oxidase), triggering a cascade of
collagen IV cross-linking [19,45] to produce amorphous, dense and
sheet-like deposition at BM on one hand, which subsequently un-
dergoes a series of structural changes based on collagen IV
uncoiling for degradation. Meanwhile, stress in ECM increases,
triggering cancer cells invade into ECM to reduce the stress. At
invasion front, cancer cells secrete MMPs to degrade collagen IV
into fragments, accompanied with triple-helix uncoiling of collagen
IV. Once collagen IV at invasion front disappears, cancer cells are
shed from large tumor nests to form new clusters. On the other
hand, LOX takes part in cross-linking fragmented collagen IV in
ECM to increase tissue stiffness, which can activate integrins [46],
drive adhesion assembly [47], inﬂuence focal adhesion formation
[48], increase focal adhesion kinase activity [49], and eventually
enhance cancer cells proliferation, invasion, migration and tumor
angiogenesis [24].
Such changes both at BM, i.e., collagen IV increase ﬁrst followed
by degradation, and in ECM, i.e., collagen IV fragments re-
deposition and linearization, contribute to forming “invasion
ﬁeld”, ﬁnally leading to collective cancer cells shedding from large
Fig. 8. Pulse-mode of cancer invasion and metastasis. As tumor mass expands, ECM remodeling occurs characterized by collagen IV changes including degradation and re-
deposition. Prominent central hypoxia cancer cells secrete LOX to cross-link collagen IV to constrain cancer cells and subsequently to be degraded followed by increasing
collagen IV deposition in ECM. Tumor mass becomes increasingly harder with tumor stroma stiffening causing high ECM stress. With cancer cells proliferation, tension becomes
increasingly higher, till reaching a critical point, where large tumor nests “burst”, releasing many tiny seeding nests and reducing the central ECM tension. The resulting seeding
tumor nests repeat the same process of tumor mass growth/prominent central hypoxia/collagen IV cross-linking and deposition/ECM remodeling/ECM stress buil-
dup/tumor nest burst, leading to accelerated cancer progression in this rich “soil” of dysfunctional tumor microenvironment.
M. Fang et al. / Biomaterials 34 (2013) 8708e87178716tumor nests to form independent small seeding tumor nests. These
seeding small tumor nests will repeat the same cycle of ECM
remodeling. Based on this study and in combination with other
reports, here we propose a “pulse-mode” of cancer progression
(Fig. 8): with cancer cells proliferation and growth of tumor nests,
dynamic changes of tumor microenvironment and co-evolution
between cancer cells and tumor microenvironment, ECM stress
increases progressively, till reaching a critical point called
“biomechanical trigger” [24], when large tumor nests “burst” to
shed off many tiny seeding cancer cells with central ECM stress
decrease. The seeding cancer cells either colonize at this “fertile
soil” of dysfunctional tumor microenvironment or migrate to
distant target organs. The newly colonized cancer cells repeat the
same process of tumor mass growth/prominent central hypo-
xia/collagen IV cross-linking and deposition/ECM remod-
eling/ECM stress buildup/tumor nest burst, but it may take lesstime to reach the trigger and “burst” again as the surrounding
microenvironment has changed to favor cancer growth and inva-
sion. In this way, cancer invasion and metastasis is greatly
enhanced by tumor nests “burst” cycle.
In terms of clinical implication, the potential signiﬁcance of this
“pulse-mode” theory is as following: (1) Strategies to decrease ECM
stress, delay or block tumor nests “burst” could be helpful to curb
cancer invasion and migration; (2) For cancer treatment, modu-
lating tumor microenvironment should be highlighted, in addition
to reducing growth and proliferate activity of cancer cells.
4. Conclusion
This study successfully combined QDs with clinical research,
which broadened the application of QDs in biomedicine. Taking
advantages of QDs-basedmultiplexed imaging technology, collagen
M. Fang et al. / Biomaterials 34 (2013) 8708e8717 8717IV representing ECM, macrophages representing cancer immune
inﬁltration, CD105 representing tumor neo-vessels and cancer cells
were imaged simultaneously. And according to the co-evolution of
cancer cells and tumor microenvironment, here we developed a
cancer invasion mode called “pulse-mode”, to deeply understand
the co-evolution of cancer cells and tumor microenvironment
during cancer progression.
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